Predict your next investment

QUIBIM company logo

See what CB Insights has to offer

Founded Year



Incubator/Accelerator - II | Alive

Total Raised



Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.

QUIBIM Headquarter Location

Avenida Aragón 30 13 Floor, Office I - J

Valencia, 46021,


+34 961 243 225

Latest QUIBIM News

Molecular imaging firms teaming up on $8.9M whole-body PET/CT project

Jul 26, 2021

A handful of nuclear medicine and molecular imaging companies are teaming up to develop a new whole-body PET/CT scanner. Leading the charge is Quibim, an artificial intelligence and medical image processing firm with offices in California and Spain. GE Healthcare is also chipping in on the $8.9 million effort, which is partially funded and led by the Valencia Government Health Project. The scanner will exceed current PET technologies, aiming to brandish a higher sensitivity by increasing axial coverage. This can be used to reduce radiation dose or acquisition times while retaining image quality, according to a July 20 announcement . "We will create automatic pipelines to obtain a virtual in vivo dissection of key organs using AI, and characterize radiotracer and radiomics features," Quibim CEO and co-founder Angel Alberich-Bayarri added. "The output of this innovative collaboration will help clinicians reading a PET exam decide on which regions they must focus on to support patient diagnosis and prognosis evaluations." Pediatric patients who require various diagnostic exams to evaluate treatment effectiveness may benefit the most, Quibim explained. Full Body Insight, a company focused on using scintillator technologies in total-body PET, and molecular imaging specialist Oncovision, are also contributing to the project. A prototype scanner is expected to be finished by 2023.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing QUIBIM

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

QUIBIM is included in 5 Expert Collections, including Artificial Intelligence.


Artificial Intelligence

8,327 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Medical Devices

11,222 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Biopharma Tech

5,239 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Health Monitoring & Diagnostics

2,707 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health

12,271 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

QUIBIM Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo


CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.